Heme oxygenase-1 and its metabolites affect pancreatic tumor growth <it>in vivo</it>
<p>Abstract</p> <p>Background</p> <p>Pancreatic cancer (PaCa) is a fatal human cancer due to its exceptional resistance to all current anticancer therapies. The cytoprotective enzyme heme oxygenase-1 (HO-1) is significantly overexpressed in PaCa and seems to play an imp...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2009-06-01
|
Series: | Molecular Cancer |
Online Access: | http://www.molecular-cancer.com/content/8/1/37 |
id |
doaj-37131b6aa2974676b99ed5071a9fe807 |
---|---|
record_format |
Article |
spelling |
doaj-37131b6aa2974676b99ed5071a9fe8072020-11-24T22:10:28ZengBMCMolecular Cancer1476-45982009-06-01813710.1186/1476-4598-8-37Heme oxygenase-1 and its metabolites affect pancreatic tumor growth <it>in vivo</it>Nuhn PhilippKünzli Beat MHennig RenéMitkus TomasRamanauskas TadasNobiling RainerMeuer Stefan CFriess HelmutBerberat Pascal O<p>Abstract</p> <p>Background</p> <p>Pancreatic cancer (PaCa) is a fatal human cancer due to its exceptional resistance to all current anticancer therapies. The cytoprotective enzyme heme oxygenase-1 (HO-1) is significantly overexpressed in PaCa and seems to play an important role in cancer resistance to anticancer treatment. The inhibition of HO-1 sensitized PaCa cells to chemo- and radiotherapy <it>in vitro</it>.</p> <p>Therefore, we investigated the effects of HO-1 and its metabolites biliverdin, carbon monoxide and iron on PaCa cells.</p> <p>PaCa cell lines with divergent HO-1 expression patterns were used in a murine orthotopic cancer model. HO-1 expression and activity was regulated by zinc (inhibition) and cobalt (induction) protoporphyrin. Furthermore, the influence of cellular HO-1 levels and its metabolites on effects of standard chemotherapy with gemcitabine was tested <it>in vivo </it>and <it>in vitro</it>.</p> <p>Results</p> <p>High HO-1 expression in PaCa cell lines was associated with increased chemoresistance <it>in vitro</it>. Chemoresistance to gemcitabine was increased during HO-1 induction in PaCa cells expressing low levels of HO-1. The inhibition of HO-1 activity in pancreatic tumors with high HO-1 boosted chemotherapeutic effects <it>in vivo </it>significantly. Furthermore, biliverdin and iron promoted PaCa resistance to chemotherapy. Consequently, specific iron chelation by desferrioxamine revealed profound anticancerous effects.</p> <p>Conclusion</p> <p>In summary, the inhibition of HO-1 and the chelation of iron in PaCa cells were associated with increased sensitivity and susceptibility of pancreatic tumors to chemotherapy <it>in vivo</it>. The metabolites biliverdin and iron seem to be involved in HO-1-mediated resistance to anticancer treatment. Therefore, HO-1 inhibition or direct interference with its metabolites may evolve new PaCa treatment strategies.</p> http://www.molecular-cancer.com/content/8/1/37 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Nuhn Philipp Künzli Beat M Hennig René Mitkus Tomas Ramanauskas Tadas Nobiling Rainer Meuer Stefan C Friess Helmut Berberat Pascal O |
spellingShingle |
Nuhn Philipp Künzli Beat M Hennig René Mitkus Tomas Ramanauskas Tadas Nobiling Rainer Meuer Stefan C Friess Helmut Berberat Pascal O Heme oxygenase-1 and its metabolites affect pancreatic tumor growth <it>in vivo</it> Molecular Cancer |
author_facet |
Nuhn Philipp Künzli Beat M Hennig René Mitkus Tomas Ramanauskas Tadas Nobiling Rainer Meuer Stefan C Friess Helmut Berberat Pascal O |
author_sort |
Nuhn Philipp |
title |
Heme oxygenase-1 and its metabolites affect pancreatic tumor growth <it>in vivo</it> |
title_short |
Heme oxygenase-1 and its metabolites affect pancreatic tumor growth <it>in vivo</it> |
title_full |
Heme oxygenase-1 and its metabolites affect pancreatic tumor growth <it>in vivo</it> |
title_fullStr |
Heme oxygenase-1 and its metabolites affect pancreatic tumor growth <it>in vivo</it> |
title_full_unstemmed |
Heme oxygenase-1 and its metabolites affect pancreatic tumor growth <it>in vivo</it> |
title_sort |
heme oxygenase-1 and its metabolites affect pancreatic tumor growth <it>in vivo</it> |
publisher |
BMC |
series |
Molecular Cancer |
issn |
1476-4598 |
publishDate |
2009-06-01 |
description |
<p>Abstract</p> <p>Background</p> <p>Pancreatic cancer (PaCa) is a fatal human cancer due to its exceptional resistance to all current anticancer therapies. The cytoprotective enzyme heme oxygenase-1 (HO-1) is significantly overexpressed in PaCa and seems to play an important role in cancer resistance to anticancer treatment. The inhibition of HO-1 sensitized PaCa cells to chemo- and radiotherapy <it>in vitro</it>.</p> <p>Therefore, we investigated the effects of HO-1 and its metabolites biliverdin, carbon monoxide and iron on PaCa cells.</p> <p>PaCa cell lines with divergent HO-1 expression patterns were used in a murine orthotopic cancer model. HO-1 expression and activity was regulated by zinc (inhibition) and cobalt (induction) protoporphyrin. Furthermore, the influence of cellular HO-1 levels and its metabolites on effects of standard chemotherapy with gemcitabine was tested <it>in vivo </it>and <it>in vitro</it>.</p> <p>Results</p> <p>High HO-1 expression in PaCa cell lines was associated with increased chemoresistance <it>in vitro</it>. Chemoresistance to gemcitabine was increased during HO-1 induction in PaCa cells expressing low levels of HO-1. The inhibition of HO-1 activity in pancreatic tumors with high HO-1 boosted chemotherapeutic effects <it>in vivo </it>significantly. Furthermore, biliverdin and iron promoted PaCa resistance to chemotherapy. Consequently, specific iron chelation by desferrioxamine revealed profound anticancerous effects.</p> <p>Conclusion</p> <p>In summary, the inhibition of HO-1 and the chelation of iron in PaCa cells were associated with increased sensitivity and susceptibility of pancreatic tumors to chemotherapy <it>in vivo</it>. The metabolites biliverdin and iron seem to be involved in HO-1-mediated resistance to anticancer treatment. Therefore, HO-1 inhibition or direct interference with its metabolites may evolve new PaCa treatment strategies.</p> |
url |
http://www.molecular-cancer.com/content/8/1/37 |
work_keys_str_mv |
AT nuhnphilipp hemeoxygenase1anditsmetabolitesaffectpancreatictumorgrowthitinvivoit AT kunzlibeatm hemeoxygenase1anditsmetabolitesaffectpancreatictumorgrowthitinvivoit AT hennigrene hemeoxygenase1anditsmetabolitesaffectpancreatictumorgrowthitinvivoit AT mitkustomas hemeoxygenase1anditsmetabolitesaffectpancreatictumorgrowthitinvivoit AT ramanauskastadas hemeoxygenase1anditsmetabolitesaffectpancreatictumorgrowthitinvivoit AT nobilingrainer hemeoxygenase1anditsmetabolitesaffectpancreatictumorgrowthitinvivoit AT meuerstefanc hemeoxygenase1anditsmetabolitesaffectpancreatictumorgrowthitinvivoit AT friesshelmut hemeoxygenase1anditsmetabolitesaffectpancreatictumorgrowthitinvivoit AT berberatpascalo hemeoxygenase1anditsmetabolitesaffectpancreatictumorgrowthitinvivoit |
_version_ |
1725808007151878144 |